Serina Therapeutics, Inc. (SER) intrinsic value & 10-year financials
Serina Therapeutics, Inc. (SER) has a Graham intrinsic value of $70.79 per share. At $1.72 on Oct 17, 2026, the stock trades 98% below that value. Over the last 10 fiscal years revenue shrank 25.7% a year to $130.0K, with an average return on invested capital of -757.5%.
- Graham intrinsic value
- $70.79
- Share price (Oct 17, 2026)
- $1.72
- Price vs Graham value
- 98% below
- Market cap
- $17.5M
- Revenue (FY2025)
- $130.0K
- Revenue growth (10-yr CAGR)
- -25.7%
- ROIC (10-yr avg)
- -757.5%
- Free cash flow (FY2025)
- -$18.0M
SER 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $130.0K | -$19.2M | -$1.91 | -$18.0M | -18478.5% | 848.8% |
| FY2024 | $56.0K | -$11.1M | -$1.51 | -$17.2M | -30442.9% | -1207.8% |
| FY2023 | $142.0K | -$14.8M | -$0.00 | -$8.3M | -6962.7% | -337.8% |
| FY2022 | $34.0K | -$10.5M | -$0.00 | — | -20514.7% | -1987.1% |
| FY2021 | $144.0K | -$8.7M | — | — | -5509.0% | -1103.7% |
| FY2020 | $1.9M | -$10.9M | — | -$7.8M | -571.3% | — |
| FY2019 | $1.7M | -$12.2M | — | -$10.8M | -726.8% | — |
| FY2018 | $1.4M | -$7.5M | — | -$8.0M | -805.5% | — |
| FY2017 | $1.4M | -$6.6M | — | -$6.3M | -474.6% | — |
| FY2016 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Serina Therapeutics, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Serina Therapeutics, Inc. has historically struggled to out-earn its cost of capital, averaging just -7.6% ROIC.
Serina Therapeutics, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Serina Therapeutics, Inc. is modeled at -25.7% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $70.79 per share.